Reply to the letter regarding “Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study”
本文未提供摘要，请点击“查看全文”查看完整内容。